News

The root cause of type 2 diabetes has been clarified by a new study, which shows that elevated blood glucose alters the metabolism of pancreatic cells. Approximately 415 million people worldwide have diabetes. Nearly five million people in the UK...

In a Phase I study that was recently published in the journal Lancet Oncology, it was shown that the first implantable pump system for individuals suffering from brain cancer could successfully kill reoccurring glioblastoma (GBM) tumour cells by continuously...

The development of a neurodegenerative disease in mice is slowed down by a novel therapy, according to researchers. The ground-breaking study may provide hope for treating conditions like Alzheimer's Disease (AD), which is regarded as incurable. Researchers at the University of...

Five COVID-19 therapies, including Merck & Co.'s antiviral tablet for high-risk patients, have been recommended for discontinuation by Britain's agency that decides whether medications may be used in the National Health Service (NHS), citing cost-effectiveness issues. As the pandemic moves...

According to the new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline from the International Generic and Biosimilar Medicines Association (IGBA), the framework provides a fantastic opportunity to re-evaluate how regulatory standards can better progress...

As a strategic member representing the Middle East, Abu Dhabi Airports has joined Pharma.Aero, a global member network for life science and medical technology manufacturers, certified cargo communities, and airport operators. The partnership with Pharma.Aero builds on Abu Dhabi's development...

Two neglected tropical illnesses, lymphatic filariasis and onchocerciasis, will receive a combined investment of about 790-million-yen ($5.3 million) from the Global Health Innovative Technology (GHIT) Fund in Japan. The parasitic worms that cause lymphatic filariasis, also known as elephantiasis, and...